TY - JOUR
T1 - Substance use treatment partially mitigates association between methamphetamine use and STI risk
T2 - Findings from the NSDUH cohort
AU - Sherman, Jessica P.
AU - Dyar, Christina
AU - Morgan, Ethan
N1 - Funding Information:
Funding This work was supported by grants from the National Institute on Drug Abuse at the National Institutes of Health (K01DA046716, Principal Investigator: CD).
Publisher Copyright:
© 2022 BMJ Publishing Group. All rights reserved.
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Background In recent years, both methamphetamine use and STIs have been on the rise in the USA. In this analysis, we sought to ascertain whether the risk of STIs and HIV among methamphetamine users was moderated on the basis of participation in substance use treatment programmes. Methods Data came from the National Survey on Drug Use and Health, 2015-2019. Among adult participants, survey-weighted logistic regression analyses were used to assess the relationship between past year methamphetamine use and risk of HIV and STIs, stratified by methamphetamine treatment utilisation and adjusted for demographic and other risk factors. Results Among participants in the analytic sample (n=210 392), 1862 (0.9%) reported past year methamphetamine use, 566 (0.3%) reported receiving treatment for its use, 5471 (2.6%) tested positive for any STI in the past year and 395 (0.2%) for HIV ever in their lifetime. Past year methamphetamine use was associated with increased risk of STIs among those who did not receive treatment (adjusted OR=3.628; 95% CI 2.75 to 4.92). Significant moderation was also present between past-year methamphetamine use, risk of STI, and substance use treatment. Conclusion In this analysis, we demonstrated a strong relationship between methamphetamine use and risk of STIs that differed based on receipt of substance use treatment. These findings suggested that integrated STI and substance use treatment programmes may yield substantial public health benefits.
AB - Background In recent years, both methamphetamine use and STIs have been on the rise in the USA. In this analysis, we sought to ascertain whether the risk of STIs and HIV among methamphetamine users was moderated on the basis of participation in substance use treatment programmes. Methods Data came from the National Survey on Drug Use and Health, 2015-2019. Among adult participants, survey-weighted logistic regression analyses were used to assess the relationship between past year methamphetamine use and risk of HIV and STIs, stratified by methamphetamine treatment utilisation and adjusted for demographic and other risk factors. Results Among participants in the analytic sample (n=210 392), 1862 (0.9%) reported past year methamphetamine use, 566 (0.3%) reported receiving treatment for its use, 5471 (2.6%) tested positive for any STI in the past year and 395 (0.2%) for HIV ever in their lifetime. Past year methamphetamine use was associated with increased risk of STIs among those who did not receive treatment (adjusted OR=3.628; 95% CI 2.75 to 4.92). Significant moderation was also present between past-year methamphetamine use, risk of STI, and substance use treatment. Conclusion In this analysis, we demonstrated a strong relationship between methamphetamine use and risk of STIs that differed based on receipt of substance use treatment. These findings suggested that integrated STI and substance use treatment programmes may yield substantial public health benefits.
KW - HIV
KW - chlamydia Infections
KW - gonorrhea
KW - substance-related disorders
KW - syphilis
UR - http://www.scopus.com/inward/record.url?scp=85105527864&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105527864&partnerID=8YFLogxK
U2 - 10.1136/sextrans-2021-055004
DO - 10.1136/sextrans-2021-055004
M3 - Article
C2 - 33952681
AN - SCOPUS:85105527864
SN - 1368-4973
VL - 98
SP - 210
EP - 214
JO - Sexually Transmitted Infections
JF - Sexually Transmitted Infections
IS - 3
ER -
